Stay updated on Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial

Sign up to get notified when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T01:47:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” across its content.
    Difference
    0.4%
    Check dated 2026-10-25T01:42:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:28:00.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T01:56:56.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study's version history. The previous revision v3.6.6 has been removed from the list.
    Difference
    0.1%
    Check dated 2026-09-20T00:58:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision tag v3.6.6 was added to the record history and the previous v3.6.5 tag was removed, updating the documented page version in the history.
    Difference
    0.1%
    Check dated 2026-08-29T21:47:08.000Z thumbnail image

Stay in the know with updates to Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pimavanserin Extension Study in Neurodegenerative Disease Clinical Trial page.